Clinical trial
Effect of Renin-angiotensin-system (RAS) Blocker Drugs on Chronic Kidney Disease (CKD) Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
NCT03195023 is registered in ClinicalTrials.gov with Hospital General Universitario Gregorio Marañon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Renin-angiotensin-system (RAS) Blocker Drugs on Chronic Kidney Disease (CKD) Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)
- Lead sponsor
- Hospital General Universitario Gregorio Marañon
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2015
- Completion date
- December 31, 2022
- Enrollment
- 106 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.